Cargando…

The FUS-DDIT3 Interactome in Myxoid Liposarcoma()

Myxoid liposarcoma is a malignant lipogenic tumor that develops in deep soft tissues. While local control rates are good, current chemotherapy options remain ineffective against metastatic disease. Myxoid liposarcoma is characterized by the FUS-DDIT3 fusion oncoprotein that is proposed to function a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Jamie S.E., Colborne, Shane, Hughes, Christopher S., Morin, Gregg B., Nielsen, Torsten O.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2019
Materias:	Original article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584455/ https://www.ncbi.nlm.nih.gov/pubmed/31220736 http://dx.doi.org/10.1016/j.neo.2019.05.004

Ejemplares similares

FUS-DDIT3 Fusion Oncoprotein Expression Affects JAK-STAT Signaling in Myxoid Liposarcoma
por: Dolatabadi, Soheila, et al.
Publicado: (2022)

Nuclear expression of FLT1 and its ligand PGF in FUS-DDIT3 carrying myxoid liposarcomas suggests the existence of an intracrine signaling loop
por: Andersson, Mattias K, et al.
Publicado: (2010)

Identification of inhibitors regulating cell proliferation and FUS-DDIT3 expression in myxoid liposarcoma using combined DNA, mRNA, and protein analyses
por: Svec, David, et al.
Publicado: (2018)

Well-Differentiated Liposarcoma of the Hypopharynx Exhibiting Myxoid Liposarcoma-like Morphology with MDM2 and DDIT3 Co-Amplification
por: Murshed, Khaled A., et al.
Publicado: (2021)

A cryptic EWSR1 :: DDIT3 fusion in myxoid liposarcoma: Potential pitfalls with FISH and cytogenetics
por: Ibstedt, Sebastian, et al.
Publicado: (2022)

Fusion protein-driven IGF-IR/PI3K/AKT signals deregulate Hippo pathway promoting oncogenic cooperation of YAP1 and FUS-DDIT3 in myxoid liposarcoma
por: Berthold, Ruth, et al.
Publicado: (2022)

DDIT3 Expression in Liposarcoma Development
por: Kåbjörn Gustafsson, Christina, et al.
Publicado: (2014)

Myxoid Liposarcoma-Associated EWSR1-DDIT3 Selectively Represses Osteoblastic and Chondrocytic Transcription in Multipotent Mesenchymal Cells
por: Suzuki, Kayo, et al.
Publicado: (2012)

Myxoid liposarcoma in a 91-year-old patient
por: Sheffield, Brandon S, et al.
Publicado: (2013)

Aggressive myxoid liposarcoma of mediastinum.
por: Sharma, B. S., et al.
Publicado: (1992)

FUS-DDIT3 Prevents the Development of Adipocytic Precursors in Liposarcoma by Repressing PPARγ and C/EBPα and Activating eIF4E
por: Pérez-Mancera, Pedro A., et al.
Publicado: (2008)

DDIT3/CHOP and the sarcoma fusion oncoprotein FUS-DDIT3/TLS-CHOP bind cyclin-dependent kinase 2
por: Bento, Christoffer, et al.
Publicado: (2009)

FUS-CHOP Promotes Invasion in Myxoid Liposarcoma through a SRC/FAK/RHO/ROCK-Dependent Pathway()
por: Tornin, Juan, et al.
Publicado: (2017)

Retroperitoneal perirenal myxoid liposarcoma
por: Crisan, Nicolae, et al.
Publicado: (2015)

Primary Retroperitoneal Myxoid Liposarcomas
por: Setsu, Nokitaka, et al.
Publicado: (2016)

Recurrent myxoid liposarcoma of the hand
por: Boyd, Carter J., et al.
Publicado: (2019)

Management of myxoid liposarcoma of the extremity
por: Tfayli, Yehia, et al.
Publicado: (2021)

Primary Orbital Myxoid Liposarcoma
por: Benavides-Huerto, Miguel Armando, et al.
Publicado: (2023)

Subcutaneous Myxoid and Round Cell Liposarcoma
por: Roh, Hyun Soo, et al.
Publicado: (2011)

Imaging of Skeletal Metastases in Myxoid Liposarcoma
por: Noble, J. L., et al.
Publicado: (2010)

Primary myxoid liposarcoma of the supraglottic larynx
por: Gleinser, David M, et al.
Publicado: (2010)

Myxoid liposarcoma: it's a hippo's world
por: Regina, Carla, et al.
Publicado: (2019)

Prognostic factors of metastatic myxoid liposarcoma
por: Shinoda, Yusuke, et al.
Publicado: (2020)

Giant Mediastinal Myxoid Pleomorphic Liposarcoma
por: Al Kindi, Adil H., et al.
Publicado: (2023)

Prognostic value of nuclear morphometry in myxoid liposarcoma
por: Kawaguchi, Kengo, et al.
Publicado: (2023)

Multicentric myxoid liposarcoma: report of two cases
por: Fernández-Aceñero, M Jesus, et al.
Publicado: (2007)

Cell Senescence in Myxoid/Round Cell Liposarcoma
por: Kåbjörn Gustafsson, Christina, et al.
Publicado: (2014)

Solitary breast metastasis from myxoid liposarcoma
por: Yokouchi, Masahiro, et al.
Publicado: (2014)

Giant myxoid liposarcoma of descending mesocolon origin
por: Uslukaya, Omer, et al.
Publicado: (2014)

About a case of paratesticular myxoid liposarcoma
por: Ayari, Yassine, et al.
Publicado: (2018)

Requirement for YAP1 signaling in myxoid liposarcoma
por: Trautmann, Marcel, et al.
Publicado: (2019)

Primary myxoid liposarcoma of the pelvis: An unusual location
por: Rico Gala, Susana, et al.
Publicado: (2020)

Myxoid liposarcoma of bladder: a rare case
por: Chudal, Sampanna, et al.
Publicado: (2021)

An inguinal enigma: Myxoid liposarcoma in a female
por: Agarwal, Shantanu, et al.
Publicado: (2023)

High-Throughput Screening of Myxoid Liposarcoma Cell Lines: Survivin Is Essential for Tumor Growth()()
por: de Graaff, Marieke A., et al.
Publicado: (2017)

Efficacy of first-line doxorubicin and ifosfamide in myxoid liposarcoma
por: Katz, Daniela, et al.
Publicado: (2012)

Myxoid Liposarcoma in the Abdominal Wall: A Case Report
por: Fan, Zhe, et al.
Publicado: (2014)

Axitinib Has Antiangiogenic and Antitumorigenic Activity in Myxoid Liposarcoma
por: Kerr, Lauren T., et al.
Publicado: (2016)

Safely combining trabectedin with radiotherapy to treat myxoid liposarcoma
por: Chen, Mark, et al.
Publicado: (2019)

Giant myxoid liposarcoma of the stomach: Report of a case
por: Sonoda, Akari, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_tpl7h4ghqrfvtu8p23cmm0ia6e